Technologies Enabling Improved Skincare

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology TOE depicts life sciences trends across skincare. Recombinant DNA technology, probiotic formulations, and phage proteins for enhanced skincare are profile in the TOE. The corresponding technology innovation scenario across skin microbiome and ageing is depicted.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative t

Table of Contents

Technologies Enabling Improved SkincareRecent Innovations for Skin HealthRecombinant DNA Technology for Enhanced SkincareLeveraging DNA Sequencing for Developing Novel Skincare Probiotic FormulationsLeveraging Phage Proteins to Target Pathogenic Skin BacteriaCustomizing Skincare Regime Based on DNA AssayResearch Advances and Industry InteractionsRecent Research Advances in Skin Microbiome and AgingSummary of Key Contacts




Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.